Use of Ketamine in Severe Pain Syndromes
NCT06537375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89
Last updated 2025-02-25
Summary
Ketamine has been shown to have a certain efficiency in chronic pain syndromes. However, it is still not clearly known what is its efficiency and how ketamine is used in real world patients. In this retrospective study, all patients treated with ketamine for chronic pain in our hospital will be reviewed. Patients demographics, pain syndromes as well as outcome criteria will be collected to describe the use of ketamine in pain syndromes.
Conditions
- Pain, Intractable
- Pain, Chronic
- Pain Syndrome
- Pain Measurement
Sponsors & Collaborators
-
Erasme University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2025-02-20
- Completion
- 2025-02-20
Countries
- Belgium
Study Locations
More Related Trials
-
Evaluating Ketamine and Psychological Sequelae
NCT04053400 ·Status: COMPLETED
-
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
NCT04977674 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Cardiovascular Safety After Continuous Ketamine Infusion
NCT03979105 ·Status: COMPLETED
-
Intra-operative Ketamine Infusions in Opioid-dependent Patients With Chronic Lower Back Pain
NCT00899600 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine
NCT00847418 ·Status: COMPLETED ·Phase: PHASE1
-
Acute Dose-dependent Effects of DMT in Healthy Subjects
NCT05384678 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants
NCT01780259 ·Status: COMPLETED ·Phase: PHASE1
-
N-acetylcysteine and NMDA Antagonist Interactions
NCT00611897 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effects of Fentanyl Abuse on Executive Function and Related Brain Activity
NCT05469217 ·Status: UNKNOWN
-
Ketamine for Low Mood States in the ER
NCT01209845 ·Status: COMPLETED ·Phase: PHASE1
-
Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects
NCT04716335 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult Participants
NCT02345148 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dimethyltryptamine in Healthy Subjects
NCT04353024 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine For Suicidal Ideation
NCT01507181 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine IV Classic Protocol : Five Years Follow up
NCT04824157 ·Status: COMPLETED
-
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394 ·Status: SUSPENDED ·Phase: PHASE3
-
Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)
NCT05695495 ·Status: COMPLETED ·Phase: PHASE1
-
Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline
NCT01794975 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
NCT04266288 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
NCT05698095 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects
NCT04173962 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
NCT05696691 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects
NCT05829603 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of DMT in Healthy Adults
NCT05901012 ·Status: COMPLETED ·Phase: PHASE1
-
Network-Level Effects of Nitrous Oxide in the Human Brain
NCT03435055 ·Status: COMPLETED ·Phase: PHASE4